June 14, 2010 - High levels of high-density lipoprotein (HDL) — known as good cholesterol — can not only make a ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
June 8, 2010 – New study findings prove continuing warfarin therapy during pacemaker or defibrillator implantation ...
June 08, 2010
June 2, 2010 – A portable point-of-care prothrombin time/international normalized ratio (PT/INR) analyzer was ...
June 02, 2010May 4, 2010 – A deal has been struck to produce a generic version of Merck & Company’s Zetia (ezetimibe). In the ...
May 04, 2010April 27, 2010 – A popular statin gained a new indication today in the European Union for prevention of major ...
April 27, 2010
April 22, 2010 — An improved formulation of epoprostenol for the treatment of primary pulmonary arterial ...
April 26, 2010April 19, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a generic version of metoprolol ...
April 18, 2010April 9, 2010 – A preclinical study shows the action of a toll-like receptor (TLR) antagonist helps reduce ...
April 08, 2010
March 30, 2010 – The FDA granted tentative approval for Teva Pharmaceutical’s abbreviated new drug application ...
March 30, 2010
March 18, 2010 – The U.S. Food and Drug Administration (FDA) today added a boxed warning to the anti-blood ...
March 23, 2010March 23, 2010 – The U.S. Food and Drug Administration (FDA) recently added a boxed warning to the anti-blood ...
March 23, 2010March 23, 2010 – The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat ...
March 23, 2010
March 19, 2010 – An experimental factor Xa inhibitor given to patients with non-valvular atrial fibrillation (AF) ...
March 19, 2010March 18, 2010 — New data from two subanalyses of the Treating to New Targets (TNT) trial showed an increased dose ...
March 18, 2010March 17, 2010 – New Results from PLATO trial suggest ticagrelor (Brilinta) leads to lower mortality and no ...
March 17, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now